Physician profile
Arthur Jacobson
NPI 1255381125
$2,462.01
in general payments reported to CMS, 2019-2025
10 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $517 · 2021: $525 · 2022: $275 · 2023: $228 · 2024: $178 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,015.74 | 2019-2025 | Clareon, Luxor, Lensx |
| Biotissue Holdings INC. | $129.55 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $89.30 | 2021 | |
| Shire North American Group INC | $47.04 | 2019 | |
| Kala Pharmaceuticals, INC. | $44.96 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $35.58 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $33.26 | 2024 | Xdemvy |
| Astellas Pharma US INC | $25.34 | 2025 | Izervay |
| Sun Pharmaceutical Industries INC. | $23.85 | 2023 | Cequa |
| Horizon Therapeutics Plc | $17.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.